Full Description
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of leukemia treatment. Leukemia treatment has undergone major change over the course of the past few years and Leukemia addresses current best practices in the light of the most recent evidence.
With contributions from experts across the US and Canada, Leukemia details the current management of different types of leukemia and reviews new therapies in development for various forms of acute leukemia, chronic leukemia, myelodysplastic syndrome, and myeloproliferative disorders. Coverage includes new developments in hematopoitic cell transplantation, leukemia pathology and management, immunotherapy and targeted therapies. It is a valuable tool for clinicians, nurses, researchers, medical students, residents, and fellows.
Emerging Cancer Therapeutics Series Titles Features:
Editorial board of nationally recognised experts across the spectrum of Cancer Therapeutics
In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics
Issues edited by an authority in specific subject area
Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience
Emphasises multidisciplinary approaches to research and practice
Contents
1. Hematopathology and Diagnostic Studies in Leukemia, Carlos Bueso-Ramos and Wesley Greaves , 2. Acute Myeloid Leukemia, Roland B. Walter and Elihu H. Estey, 3. Chronic Myeloid Leukemia, Elias Jabbour, Hagop Kantarjian, and Jorge Cortes, 4. Adult Acute Lymphoblastic Leukemia, Anna Z. Castleton and Adele K. Fielding, 5. The Myelodysplastic Syndromes, Yanis Boumber and Guillermo Garcia-Manero, 6. Myelofibrosis, Fabio P.S. Santos and Srdan Verstovsek, 7. Chronic Lymphocytic Leukemia, Preetesh Jain and Kanti R. Rai, 8. Reduced-Intensity Allogeneic Transplantation, Uday Popat, 9. Alternative Donor Transplantation for Adult Leukemia, Melhem Solh, and Navneet S. Majhail, 10. Immunotherapy for Leukemia, Caroline Arber, Barbara Savoldo, and Gianpietro Dotti, 11. Novel and Targeted Therapies in Leukemia, Amber Fullmer, Hagop Kantarjian, and Elias Jabbour, 12. Infections in Patients with Leukemia, Shashank S. Ghantoji and Roy F. Chemaly
